author-photo

Harpreet Singh

National Institutes of Health

11

Papers

145

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma

2018 Molecular & Cellular Proteomics
Show All
- Source
- Cite
- Save
Citations (42)
Sorafenib but not sunitinib affects the induction of immune responses

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
17LBA Results from an open-label, randomized, controlled Phase 3 study investigating IMA901 multipeptide cancer vaccine in patients receiving sunitinib as first-line therapy for advanced/metastatic RCC

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (18)
Combining active immunotherapy and immune checkpoint inhibitors in prostate cancer.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Abstract 5012: A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: Immune correlates

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Immune responses and association with clinical outcome of advanced colorectal cancer patients treated with the multi-peptide vaccine IMA910.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Overall survival (OS) of advanced colorectal cancer (aCRC) patients (pts) treated with the multipeptide vaccine IMA910: Results of a matched-pair analysis with arm C pts from COIN

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
IMA901 Multipeptide Vaccine Randomized International Phase III Trial (IMPRINT): A randomized, controlled study investigating IMA901 multipeptide cancer vaccine in patients receiving sunitinib as first-line therapy for advanced/metastatic RCC.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (16)
Correlation of immune responses with survival in a randomized phase II study investigating multipeptide vaccination with IMA901 plus or minus low-dose cyclophosphamide in advanced renal cell carcinoma (RCC).

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Results of a randomized phase II study investigating multipeptide vaccination with IMA901 in advanced renal cell carcinoma (RCC).

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (36)